Position in ADCT
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$33,795
+$2,294 QoQ
Shares Held
9,012
+1.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $884,912,076 across 47 Drug Manufacturers - Specialty & Generic names. ADCT ranks #40 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,650,753 | $431,555,511 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,872,811 | $116,649,065 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
186,794 | $110,765,104 | |
| 4 | VTRS |
Viatris Inc
|
3,838,534 | $51,858,592 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
380,589 | $50,138,793 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
709,808 | $16,985,705 | |
| 7 | ALKS |
Alkermes plc.
|
380,722 | $13,462,329 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,411,199 | $13,434,613 |
All Filings in ADCT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,795 | 9,012 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $31,501 | 8,924 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $32,340 | 8,085 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $21,667 | 8,085 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $12,037 | 8,537 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $16,988 | 8,537 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $26,891 | 8,537 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $22,388 | 7,085 | Shares | Defined | 2025-05-29 | |
| 2020-06-30 | $117,025 | 2,500 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||